Bourdage Becomes COO As Sandoz Shuffles Management
Chief Business Officer Carol Lynch Departs As Hayling Becomes CSO
A management reshuffle at Sandoz has seen head of biopharmaceuticals Pierre Bourdage take on the role of chief operating officer among a number of changes, as parent company Novartis continues its strategic review of the generics and biosimilars unit.
